Trials / Completed
CompletedNCT00898872
SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- SWOG Cancer Research Network · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Collecting and storing samples of tissue from patients with non-Hodgkin lymphoma to study in the laboratory may help the study of cancer in the future. PURPOSE: This laboratory study is collecting and storing tissue samples from patients with relapsed or recurrent non-Hodgkin lymphoma after treatment on a Southwest Oncology Group (SWOG) clinical trial.
Detailed description
OBJECTIVES: * Acquire fresh snap-frozen lymphoma tissue from patients with relapsed or recurrent non-Hodgkin lymphoma after treatment on a Southwest Oncology Group (SWOG) clinical trial. * Establish a standard set of procedures for routine acquisition, banking, and study of lymphoma tissues within the SWOG. * Use repository tissue to establish clinical correlations via presently activated phenotyping studies and future projected molecular studies assessing specimen DNA and RNA status. * Examine the biology of therapy failure in relationship to changes in pretreatment and post-treatment immunophenotypic data. OUTLINE: This is a multicenter study. Tissues collected at biopsy are snap-frozen and archived for future molecular and genetic studies. PROJECTED ACCRUAL: Not specified
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | cryopreservation |
Timeline
- Start date
- 1993-03-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2009-05-12
- Last updated
- 2013-05-20
Locations
82 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00898872. Inclusion in this directory is not an endorsement.